Can low zinc reduce thyroid hormone signaling even when thyroid hormone levels look normal?

Zinc is an essential trace element required for the synthesis, conversion, and cellular action of thyroid hormones.

Mechanistic explanations

• Receptor conformation: The DNA-binding domains of thyroid hormone receptors (TRα and TRβ) contain two zinc-finger motifs coordinated by zinc ions. Zinc deficiency impairs TR folding and dimerization, disrupting high-affinity receptor-DNA binding and blunting downstream transcriptional responses to triiodothyronine ($\text{T}_3$).
• Deiodinase impairment: Zinc serves as an obligate structural cofactor for type I and type II deiodinases (D1 and D2). Depletion of zinc compromises these enzymes, reducing the peripheral conversion of inactive thyroxine ($\text{T}_4$) to active $\text{T}_3$, thereby diminishing intracellular active hormone levels and subsequent signaling.

Systemic feedback and clinical implications

• HPT axis disruption: Zinc deficiency alters the hypothalamic-pituitary-thyroid (HPT) axis feedback loop. It blunts hypothalamic thyrotropin-releasing hormone (TRH) synthesis and compromises pituitary thyroid-stimulating hormone (TSH) synthesis and secretion.
• Cellular hypothyroidism: Because peripheral conversion and receptor binding are compromised while circulating $\text{T}_4$ levels may initially remain normal, low zinc can cause a state of cellular-level hypothyroidism, mimicking thyroid hormone resistance despite seemingly adequate circulating hormone levels.

Bottom line

• Zinc deficiency disrupts thyroid signaling at multiple levels—impairing deiodinase-mediated $\text{T}_4$-to-$\text{T}_3$ conversion, altering HPT axis feedback, and destabilizing the zinc-finger domains of thyroid hormone receptors. This can lead to localized, intracellular hypothyroidism and impaired thyroid action even in the presence of normal circulating thyroid hormone levels.